Totals
- Total revenue
- $2,402,192
- Total expenses
- $2,352,337
- Contributions and grants received
- $2,394,842
- Grants paid
- $1,101,158
- Program service revenue
- $0
- Investment income
- $7,350
- Other revenue
- $0
- Total assets, end of year
- $319,651
- Total liabilities, end of year
- $164,817
- Net assets or fund balances, end of year
- $154,834
- Program services expenses (Part IX)
- $2,009,371
- Management and general expenses
- $183,744
- Fundraising expenses
- $159,222
- Program service expenses (Part III)
- $2,009,371
Program services were 85.4% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1f · All other contributions, gifts and grants
$2,394,842
-
3 · Investment income
total $7,350 · excluded $7,350
-
8c · Net income from fundraising events
total $0
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $1,101,158 · program services $1,101,158
-
5 · Compensation of officers, directors and key employees
total $450,023 · program services $360,019 · management and general $67,503 · fundraising $22,501
-
7 · Other salaries and wages
total $344,204 · program services $198,205 · management and general $34,421 · fundraising $111,578
-
8 · Pension plan contributions
total $22,933 · program services $17,418 · management and general $2,293 · fundraising $3,222
-
9 · Other employee benefits
total $68,526 · program services $52,046 · management and general $6,853 · fundraising $9,627
-
10 · Payroll taxes
total $33,382 · program services $25,354 · management and general $3,338 · fundraising $4,690
-
11a · Fees: management
total $33,957 · program services $23,956 · management and general $10,001
-
11b · Fees: legal
total $700 · management and general $700
-
11c · Fees: accounting
total $41,125 · management and general $41,125
-
12 · Advertising and promotion
total $3,567 · fundraising $3,567
-
13 · Office expenses
total $25,324 · program services $20,259 · management and general $3,799 · fundraising $1,266
-
16 · Occupancy
total $55,415 · program services $44,332 · management and general $8,312 · fundraising $2,771
-
17 · Travel
total $6,531 · program services $6,531
-
19 · Conferences, conventions and meetings
total $92,892 · program services $92,892
-
23 · Insurance
total $5,399 · management and general $5,399
-
24a · Other expenses: Program Research
total $67,201 · program services $67,201
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $157,941 · end of year $315,433
-
3 · Pledges and grants receivable
beginning of year $869,068
-
15 · Other assets
beginning of year $4,218 · end of year $4,218
-
17 · Accounts payable and accrued expenses
beginning of year $83,032 · end of year $24,444
-
18 · Grants payable
beginning of year $699,068
-
25 · Other liabilities
beginning of year $144,148 · end of year $140,373
-
27 · Net assets without donor restrictions
beginning of year $104,979 · end of year $154,834
Mission and programs · 2024
Mission
See Schedule O.
-
Withheld by Nonprofiteer: this text may name a private individual.
Expenses $1,081,014 · Grants $592,408
-
RUNX1-ALSF: Sponsored Research. 2024 co-funding partnership with Alexs Lemonade Stand Foundation (ALSF) continued, a wide array of ground breaking research projects spanning basic science honing in on gene regulatory networks affected by RUNX1 mutations, classification of RUNX1 variants via novel saturation mutagenesis methods, modeling clonal evolution driven by common secondary somatic mutations, development of clinical consensus guidelines for RUNX1-FPD and defining the role of NLRP3 inflammasome in RUNX1 deficiency.
Expenses $472,162 · Grants $258,750
-
American Cancer Society: RRP launched a co-funding partnership with ACS to fund both team awards and individual awards to support early clinical trials and/or translational research aimed at preventing the onset of blood cancers in RUNX1-FPD. The application deadline was in 2024 and the announcements for these 4 year grants will be made in 2025.
Expenses $456,195 · Grants $250,000
As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here. A text marked withheld matched a screen for wording that may name a private individual, such as an honorific or "in memory of". Most of what it withholds names no one; it is withheld so that what does is never shown.
Listed in Part VII
-
Katrin Ericson
President Executive Director
- Total calculated
- $450,023
- From this org
- $450,023
- From related orgs
- $0
- Other
- $0
- Hours/week
- 55
Schedule J breakdown matched by us
- Base
- $322,395
- Bonus
- $127,628
- Other
- not reported
- Deferred
- not reported
- Nontaxable benefits
- not reported
- Filer's total
- $450,023
-
Amanda Eggen
Director of Patient Engagement
- Total calculated
- $159,803
- From this org
- $147,966
- From related orgs
- $0
- Other
- $11,837
- Hours/week
- 50
Schedule J breakdown matched by us
- Base
- $147,966
- Bonus
- not reported
- Other
- not reported
- Deferred
- $11,837
- Nontaxable benefits
- not reported
- Filer's total
- $159,803
-
Alex Gonzalez
Director of Development
- Total calculated
- $145,921
- From this org
- $139,473
- From related orgs
- $0
- Other
- $6,448
- Hours/week
- 40
-
Timothy Babich
Chairperson
- Total calculated
- $0
- Hours/week
- 5
-
Monica Babich
Secretary Treasurer CFO
- Total calculated
- $0
- Hours/week
- 5
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
- 3 · Written employment contract
- 3 · Approval by the board or compensation committee
Answered no
- 4a · Severance or change-of-control payment
- 4b · Supplemental nonqualified retirement plan
- 4c · Equity-based compensation arrangement
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 7 · Other non-fixed payments
- 8 · Paid under the initial-contract exception
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
-
$328,750
RUNX1 Foundation - Independent Grants
-
$250,000
Grants
-
Childrens Hospital of Philadelphia
$148,750
Independent RRP Grant
-
University of Texas MD Anderson
$109,058
RUNX1 Foundation - Independent Grants
-
Familial RUNX1 Research ALSF
-
University of Washington Medicine
$30,000
Early Career Investigator ALSF
-
Early Career Investigator ALSF
-
$30,000
ECI Clinical Researcher
-
Early Career Investigator ALSF
-
$30,000
Early Career Investigator ALSF
The 10 largest by cash amount. The API serves every itemized grant.
Provenance
- Return type
- form_990
- Tax year
- 2024
- Filed
- 27 June 2025
- IRS schema version
- 2024v5.1
- Source object
- 202521829349300012
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.